PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation

Advances in Enzyme Regulation

Volumn 37, Issue , 1997, Pages 239-267

  Lawrence Jr , John C ^a   Fadden, Patrick ^a   Haystead, Timothy A J ^a   Lin, Tai An ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH FACTOR; GROWTH PROMOTOR; INITIATION FACTOR; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHAS-I PROTEIN; PHAS-II PROTEIN; PHOSPHOPROTEIN; PROTEIN; PROTEIN KINASE; RNA BINDING PROTEIN;

ADIPOCYTE; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CELL DIVISION; CELL PROLIFERATION; CHEMISTRY; CONFERENCE PAPER; DEPHOSPHORYLATION; DRUG EFFECT; HORMONE ACTION; HUMAN; METABOLISM; MOLECULAR GENETICS; NONHUMAN; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSLATION INITIATION; TRANSLATION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELL DIVISION; CYCLIC AMP; EUKARYOTIC INITIATION FACTORS; GROWTH SUBSTANCES; HUMANS; INSULIN; MOLECULAR SEQUENCE DATA; PEPTIDE INITIATION FACTORS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0030866101     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(96)00016-7     Document Type: Conference Paper

References (103)

1. 1. J. AVRUCH, G. R. LEONE and D. B. MARTIN, Effects of epinephrine and insulin on phosphopeptide metabolism in adipocytes, J. Biol. Chem. 251, 1511-1515 (1976).
2. 2. W. B. BENJAMIN and I. SINGER, Actions of insulin, epinephrine and dibutyryl cyclic adenosine 3′,5′-monophosphate on fat cell protein metabolism. Cyclic adenosine 3′,5′-monophosphate dependent and independent mechanisms, Biochemistry 14, 3301-3309 (1975).
3. 3. A. M. GRESSNER and I. G. WOOL, Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6, Nature 259, 148-150 (1976).
4. 4. C. J. SMITH, P. J. WEJKSNORA, J. R. WARNER, C. S. RUBIN and O. M. ROSEN, Insulin-stimulated protein phosphorylation in 3T3-L1 preadipocytes, Proc. Natl Acad. Sci. U.S.A. 76, 2725-2729 (1979).
5. 5. M. C. ALEXANDER, E. M. KOWALOFF, L. A. WITTERS, D. T. DENNIHY and J. AVRUCH, Purification of a hepatic 123 000-dalton hormone-stimulated 32P-peptide and its identification as ATP-citrate lyase, J. Biol. Chem. 254, 8052-8056 (1979).
6. 6. S. RAMAKRISHNA and W. B. BENJAMIN, Fat cell protein phosphorylation. Identification of phosphoprotein-2 as ATP-citrate lyase, J. Biol. Chem. 254, 9232-9236 (1979).
7. 7. C. HU, S. PANG, X. KONG, M. VELLECA and J. C. LAWRENCE Jr., Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors, Proc. Natl Acad. Sci. U.S.A. 91, 3730-3734 (1994).
8. 8. R. M. DENTON, R. W. BROWNSEY and G. J. BELSHAM, A partial view of the mechanism of insulin action, Diabetologia 21, 347-362 (1981).
9. 9. T. A. J. HAYSTEAD, C. M. M. HAYSTEAD, C. HU, T.-A. LIN and J. C. LAWRENCE Jr, Phosphorylation of PHAS-I by mitogen-activated protein (MAP) kinase. Identification of a site phosphorylated by MAP kinase in vitro and in response to insulin in adipocytes, J. Biol. Chem. 269, 23185-23191 (1994).
10. 10. A. PAUSE, G. J. BELSHAM, A. C. GINGRAS, O. DONZE., T.-A. LIN, J. C. LAWRENCE Jr. and N. SONENBERG, Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′,-cap function, Nature 371, 762-767 (1994).
11. 11. J. W. B. HERSHEY, Translational control in mammalian cells, Ann. Rev. Biochem. 60, 717-755 (1991).
12. 12. W. C. MERRICK, Mechanism and regulation of eucaryotic protein synthesis, Microbiol. Rev. 56, 291-315 (1992).
13. 13. A. J. SHATKIN, mRNA caps - old and newer hats, Bioessays 7, 275-277 (1987).
14. 14. M. ALTMANN and H. TRACHSEL, Regulation of translation initiation and modulation of cellular physiology, TIBS 18, 429-432 (1993).
15. 15. R. E. RHOADS, Regulation of eukaryotic protein synthesis by initiation factors, J. Biol. Chem. 268, 3017-3020 (1993).
16. 16. N. SONENBERG, Regulation of translation and cell growth by eIF-4E, Biochimie 76, 839-846 (1994).
17. 17. M. KOZAK, Structural features in eukaryotic mRNAs that modulate the initiation of translation, J. Biol. Chem. 266, 19867-19870 (1991).
18. 18. A. E. KOROMILAS, A. LAZARIS-KARATZAS and N. SONENBERG, mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiating factor eIF-4E, EMBO J. 11, 4153-4158 (1992).
19. 19. M. RAU, T. OHLMANN, S. J. MORLEY and V. M. PAIN, A reevaluation of the cap-binding protein, eIF-4E, as a rate-limiting factor for initiation of translation in reticulocyte lysate, J. Biol. Chem. 271, 8983-8990 (1996).
20. 20. T.-A. LIN, X. KONG, T. A. J. HAYSTEAD, A. PAUSE, G. BELSHAM, N. SONENBERG and J. C. LAWRENCE Jr, PHAS-I as a link between the MAP kinase and translation initiation, Science 266, 653-656 (1994).
21. 21. L. M. GRAVES, K. E. BORNFELDT, G. M. ARGAST, E. G. KREBS, X. KONG, T.-A. LIN and J. C. LAWRENCE Jr., cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells, Proc. Natl Acad. Sci. USA 92, 7222-7226 (1995).
22. 22. T.-A. LIN, X. KONG, A. R. SALTIEL, P. J. BLACKSHEAR and J. C. LAWRENCE Jr, Control of PHAS-I by insulin in 3T3-L1 adipocytes: synthesis, degradation, and phosphorylation by a rapamycin-sensitive and MAP kinase-independent pathway, J. Biol. Chem. 270, 18531-18538 (1995).
23. 23. S. J. MORLEY and V. M. PAIN, Translational regulation during activation of peripheral blood lymphocytes: association and phosphorylation of the α and γ subunits of the initiation factor complex eIF-4F, Biochem. J. 312, 627-635 (1995).
24. 24. I. AZPIAZU, A. R. SALTIEL, A. A. DEPAOLI-ROACH and J. C. LAWRENCE Jr, Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways, J. Biol. Chem. 271, 5033-5039 (1996).
25. 25. G. J. BRUNN, J. WILLIAMS, C. SABERS, G. WIEDERRECHT, J. C. LAWRENCE Jr and R.T. ABRAHAM, Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and Ly294002, EMBO J. 15, 5256-5267 (1996).
26. 26. T. A. DIGGLE, S. K. MOULE, M. B. AVISON, A. FLYNN, E. J. FOULSTONE, C. G. PROUD and R. M. DENTON, Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells, Biochem. J. 316, 447-453 (1996).
27. 27. S. R. KIMBALL, L. S. JEFFERSON, P. FADDEN, T. A. J. HAYSTEAD and J. C. LAWRENCE Jr, Insulin and diabetes cause reciprocal changes in the association of eIF-4E and PHAS-I in rat skeletal muscle, Am. J. Physiol. 270, C705-C709 (1996).
28. S6K pathway, Diabetologia 36, In press (1997).
29. 29. A. HAGHIGHAT, S. MADER, A. PAUSE and N. SONENBERG, Repression of cap-dependent translation initiation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E-EMBO J. 14, 5701-5709 (1995).
30. 30. J. C. LAWRENCE, JR., T.-A. LIN, X. KONG, T. A. J. HAYSTEAD and C. HU, PHAS-I, a new player in the control of protein synthesis by insulin, pp. 622-629 in Diabetes 1994 (S. BABA and T. KANEKO, eds.). Elsevier Science, Amsterdam (1995).
31. 31. S. MADER, H. LEE, A. PAUSE and N. SONENBERG, The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4γ and the translational repressors 4E-binding proteins, Mol Cell. Biol. 15, 4990-4997 (1995).
32. 32. R. M. FREDERICKSON and N. SONENBERG, eIF-4E phosphorylation and the control of protein synthesis, pp. 143-148 in Translational Regulation of Gene Expression 2 (J. ILAN ed.). Plenum Press, NY (1993)
33. 33. R. E. RHOADS, Protein synthesis, cell growth and oncogenesis, Curr. Opin. Cell Biol. 3, 1019-1024 (1991).
34. 34. D. R. GALLIE and J. A. TRAUGH, Serum and insulin regulate cap function in 3T3-L1 cells, J. Biol. Chem. 269, 7174-7179 (1994).
35. 35. J. M. MANZELLA, W. RYCHLIK, R. E. RHOADS, J. W.B. HERSHEY and P. J. BLACKSHEAR, Insulin induction of ornithine decarboxylase, Importance of mRNA secondary structure and phosphorylation of eucaryotic initiation factors eIF4B and eIF-4E. J. Biol. Chem. 266, 2383-2389 (1991).
36. r-22 000 protein in 3T3-L1 adipocytes, Biochem. J. 214, 11-19 (1983).
37. 37. P. J. BLACKSHEAR, R. A. NEMENOFF and J. AVRUCH, Preliminary characterization of a heat-stable protein from rat adipose tissue whose phosphorylation is stimulated by insulin, Biochem. J. 204, 817-824 (1982).
38. 38. T. A. DIGGLE and R. M. DENTON, Comparison of the effects of insulin and adrenergic agonists on the phosphorylation of an acid-soluble 22 kDa protein in rat epididymal fat-pads and isolated fat-cells, Biochem. J. 282, 729-736 (1992).
39. 39. P. J. BLACKSHEAR, L. A. WITTERS, P. R. GIRARD, J. F. KUO and S. N. QUAMO, Growth factor-stimulated protein phosphorylation in 3T3-L1 cells. Evidence for protein kinase C-dependent and -independent pathways, J. Biol. Chem. 260, 13304-13315 (1985).
40. 40. P. FADDEN, T. A. J. HAYSTEAD and J. C. LAWRENCE Jr, Identification of phosphorylation sites in the translational regulator PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes, J. Biol. Chem., In press (1997)
41. 41. M. H. COBB, S. XU, J. E. J. HEPLER, M. HUTCHISON, J. FROST and D. J. ROBBINS, Regulation of the MAP kinase cascade, Cell. Mol. Biol. Res. 40, 253-256 (1994).
42. 42. A. FLYNN and C. G. PROUD, Insulin-stimulated phosphorylation of initiation factor 4E is mediated by the MAP kinase pathway, FEBS Lett. 389, 162-166 (1996).
43. 43. W. B. MINICH, M. L. BALASTA, D. J. GOSS and R. E. RHOADS, Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form, Proc. Natl Acad. Sci. U.S.A. 91, 7668-7672 (1994).
44. 53 mutant eukaryotic initiation factor 4E overexpression in mammalian cells, J. Biol. Chem. 268, 11902-11909 (1993).
45. 45. A. FLYNN and C. PROUD, Serine 209, not serine 53, is the major site of phosphorylation in initiation factor eIF-4E in serum-treated Chinese hamster ovary cell, J. Biol. Chem. 270, 21684-21688 (1995).
46. 46. B. JOSHI, A.-L. CAI, B. D. KEIPER, W. B. MINICH, R. MENDEZ, C. M. BEACH, J. STEPINSKI, R. STOLARSKI, E. DARZYNKIEWICZ and R. E. RHOADS, Phosphorylation of eukaryotic protein synthesis initiation factor 4E at Ser-209, J. Biol. Chem. 270, 14597-14603 (1995).
47. 47. A. MAKKINJE, H. XIONG, M. LI and Z. DAMUNI, Phosphorylation of eukaryotic protein synthesis initiation factor 4E by insulin-stimulated protamine kinase, J. Biol. Chem. 270, 14824-14828 (1995).
48. 48. S. G. WHALEN, A.-C. GINGRAS, L. AMANKWA, S. MADER, P. E. BRANTON, R. AEBERSOLD and N. SONENBERG, Phosphorylation of eIF-4E on Ser 209 by protein kinase C is inhibited by the translational repressors, 4E-binding proteins, J. Biol. Chem. 271, 11831-11837 (1996).
49. 49. D. R. ALESSI, A. CUENDA, P. COHEN, D. T. DUDLEY and A. R. SALTIEL, PD 098059 is a specific inhibitor of the activation of MAP kinase kinase in vitro and in vivo, J. Biol. Chem. 270, 27489-27494 (1995).
50. 50. T.-A. LIN and J. C. LAWRENCE Jr Control of the translational regulators, PHAS-I and PHAS-II, by insulin and cAMP in 3T3-L1 adipocytes, J. Biol. Chem. 271, 30199-30204 (1996).
51. 51. M. J. SERVANT, E. GIASSON and S. MELOCHE, Inhibition of growth factor-induced protein synthesis by a selective MEK. inhibitor in aortic smooth muscle cells, J. Biol. Chem. 271, 16047-16052 (1996).
52. 52. A. DE BENEDETTI and R. E. RHOADS, Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology, Proc. Natl Acad. Sci. U.S.A. 87, 8212-8216 (1990).
53. 53. A. DE BENEDETTI, S. JOSHI-BARVE, C. RINKER-SCHAEFFER and R. E. RHOADS, Expression of antisense RNA against initiation factor eIF-4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF-4E and the p220 component of eIF-4F, Mol. Cell. Biol. 11, 5435-5445 (1991).
54. 54. M. R. SMITH, M. JARAMILLO, Y.-L. LIU, T. E. DEVER, W. C. MERRICK, H.-F. KUNG and N. SONENBERG, Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells, New Biologist 2, 648-654 (1990).
55. 55. A. LAZARIS-KARATZAS, K. S. MONTINE and N. SONENBERG, Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap, Nature 345, 544-547 (1990).
56. 56. A. LAZARIS-KARATZAS, M. R. SMITH, R. M. FREDERICKSON, M. L. JARAMILLO, Y. L. LIU, H. F. KUNG and N. SONENBERG, Ras mediates translation initiation factor 4E-induced malignant transformation, Genes and Development 6, 1631-1642 (1992).
57. 57. M. KOZAK, An analysis of vertebrate mRNA sequences: intimations of translational control, J. Cell Biol. 115, 887-903 (1991).
58. 58. A. DE BENEDETTI, B. JOSHI, J. R. GRAFF and S. G. ZIMMER, CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require overexpression of Max for tumorigenicity, Mol. Cell. Differential. 2, 309-334 (1994).
59. 59. I. B. ROSENWALD, A. LAZARIS-KARATZAS, N. SONENBERG and E. V. SCHMIDT, Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E, Mol. Cell. Biol. 13, 7358-7363 (1993).
60. 60. F. LEJBKOWICZ, C. GOYER, A. DARVEAU, S. NERON, R. LEMIEUX and N. SONENBERG, A fraction of the mRNA 5′ cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus, Proc. Natl Acad Sci. U.S A. 89, 9612-9616 (1992).
61. 61. P. J. KENNELLY and E. G. KREBS, Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases, J. Biol. Chem. 266, 15555-15558 (1991).
62. 62. P. COHEN, B. W. GIBSON and C. F.B. HOLMES, Analysis of the in vivo phosphorylation states of proteins by fast atom bombardment mass spectrometry and other techniques, Met. Enzymol. 201, 153-168 (1991).
63. 63. A. R. SALTIEL, Diverse signaling pathways in the cellular actions of insulin, Am. J. Physiol. 270, E375-E385 (1996).
64. 64. M. F. WHITE and C. R. KAHN, The insulin signaling system, J. Biol. Chem. 269, 1-4 (1994).
65. 65. T. PAWSON, SH2 and SH3 domains in signal transduction, Adv. Cancer Res. 64, 87-110 (1994).
66. 66. R. T. ABRAHAM and G. J. WIEDERRECHT, Immunopharmacology of rapamycin, Annu. Rev. Immunol. 14, 483-510 (1996).
67. 67. C. G. PROUD, p70 S6 kinase: an enigma with variations, Trends Biochem. Sci. 21:181-185 (1996).
68. ras-GTP formation, J. Biol. Chem. 269, 10734-10738 (1994).
69. 69. J. S. CAMPBELL, R. SEGER, J. D. GRAVES, L. M. GRAVES, A. M. JENSEN and E. G. KREBS, The MAP kinase cascade, Rec. Prog. Hormone Res. 50, 131-159 (1995).
70. 70. L. CLAESSON-WELSH, Mechanism of action of platelet-derived growth factor, Int. J. Biochem. Cell. Biol. 28, 373-385 (1996).
71. 71. P. ACKERMAN and N. OSHEROFF, Regulation of casein kinase II activity by epidermal growth factor in human A-431 carcinoma cells, J. Biol. Chem. 264, 11958-11965 (1989).
72. 72. T. A. DIGGLE, C. SCHMITZ-PEIFFER, A. C. BORTHWICK, G. I. WELSH and R. M. DENTON, Evidence that insulin activates casein kinase 2 in rat epididymal fat-cells and that this may result in the increased phosphorylation of an acid-soluble 22 kDa protein, Biochem. J. 279, 545-551 (1991).
73. 73. J. K. KLARLUND and M. P. CZECH, Insulin-like growth factor I and insulin rapidly increase casein kinase II activity in BALB/c 3T3 fibroblasts, J. Biol. Chem. 263, 15872-15875 (1988).
74. 74. D. W. LITCHFIELD, G. DOBROWOLSKA and E. G. KREBS, Regulation of casein kinase II by growth factors: a reevaluation, Cell. Mol. Biol. Res. 40, 373-381 (1994).
75. 75. L. BERETTA, A.-C. GINGRAS, Y. V. SVITKIN, M. N. HALL and N. SONENBERG, Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation, EMBO J 15, 658-664 (1996).
76. 76. S. R. VON MANTEUFFEL, A. C. GINGRAS, X.-F. MING, N. SONENBERG and G. THOMAS, 4E-BP1 phosphorylation is mediated by the FRAP-p70S6K pathway and is independent of mitogen-activated protein kinase, Proc. Natl Acad. Sci. U.S.A. 93, 4076-4080 (1996).
77. 77. V. CALVO, C. M. CREWS, T. A. VIK and B. BIERER, Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin, Proc. Natl Acad. Sci. U.S.A. 89, 7571-7575 (1992).
78. 78. J. CHUNG, C. J. KUO, G. R. CRABTREE and J. BLENIS, Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases, Cell 69, 1227-1236 (1992).
79. 79. C. J. KUO, J. CHUNG, D. F. FIORENTINO, W. M. FLANAGAN, J. BLENIS and G. CRABTREE, Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase, Nature 358, 70-73 (1992).
80. 80. D. J. PRICE, J. R. GROVE, V. CALVO, J. AVRUCH and B. E. BIERER, Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase, Science 257, 973-977 (1992).
81. 81. H. B. JEFFERIES, C. REINHARD, S. C. KOZMA and G. THOMAS, Rapamycin selectively represses translation of the 'polypyrimidine tract' mRNA family, Proc. Natl Acad. Sci. U.S.A. 91, 4441-4445 (1994).
82. 82. M. UI, T. OKADA, K. HAZEKI and O. HAZEKI, Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase, Trends Biochem. Sci. 20, 303-307 (1995).
83. 83. M. MONFAR, K. P. LEMON, T. C. GRAMMER, B. L. CHEATHAM, J. CHUNG, C. J. VLAHOS and J. BLENIS, Activation of pp70/85 S6 kinases by interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cAMP, Mol. Cell. Biol. 15, 326-337 (1995).
84. 84. C. PETRITSCH, R. WOSCHOLSKI, H. M. EDELMANN and L. M. BALLOU, Activation of p70 S6 kinase and erk-encoded mitogen-activated protein is resistant to high cyclic nucleotide levels in Swiss 3T3 fibroblasts, J. Biol. Chem. 270, 26619-26625 (1995).
85. 85. V. FROST, S. J. MORLEY, L. MERCEP, T. MEYER, D. FABBRO and S. FERRARI, The phosphodiesterase inhibitor SQ20006 selectively blocks mitogen activation of p70S6k and transition to S phase of the cell division cycle without affecting the steady state phosphorylation of eIF-4E, J. Biol. Chem. 270, 26698-26706 (1995).
86. 86. L. M. GRAVES and J. C. LAWRENCE Jr, Insulin, growth factors, and cAMP. Antagonism in the signal transduction pathways, Trends Endocrinol. Metab. 7, 43-50 (1996).
87. 87. S. L. SCHREIBER, Chemistry and biology of the immunophilins and their immunosuppressive ligands, Science 251, 283-287 (1991).
88. 88. J. KUNZ and M. N. HALL, Cyclosporin A, FK506 and rapamycin: more than just immunosuppression, Trends Biochem. Sci. 18, 334-338 (1993).
89. 89. E. J. BROWN, M. W. ALBERS, T. B. SHIN, K. ICHIKAWA, C. T. KEITH, W. S. LANE and S. L. SCHREIBER, A mammalian protein targeted by G1-arresting rapamycin-receptor complex, Nature 369, 756-758 (1994).
90. 90. D. M. SABATINI, H. ERDJUMENT-BROMAGE, M. LUI, P. TEMPST and S. H. SNYDER, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs, Cell 78, 35-43 (1994).
91. 91. M. E. CARDENAS and J. HEITMAN, FKBP-12-rapamycin target Tor2 is a vacuolar protein with an associated phosphatidylinositol-4 kinase activity, EMBO J. 14, 5892-5907 (1995).
92. 92. D. M. SABATINI, B. A. PIERCHALA, R. K. BARROW, M. J. SCHELL and S. H. SNYDER, The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity, J. Biol. Chem. 270, 20875-20878 (1995).
93. 93. E. J. BROWN, P. A. BEAL, C. T. KEITH, J. CHEN, T. B. SHIN and S. L. SCHREIBER, Control of p70 S6 kinase by kinase activity of FRAP in vivo, Nature 377, 441-446 (1995).
94. 94. T. HUNTER, When is a lipid kinase not a lipid kinase? When it is a protein kinase, Cell 83, 1-4 (1995).
95. 95. C. T. KEITH and S. L. SCHREIBER, PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints, Science 270, 50-51 (1995).
96. 96. C. J. SABERS, M. M. MARTIN, G. J. BRUNN, J. M. WILLIAMS, F. J. DUMONT, G. WIEDERRECHT and R. T. ABRAHAM, Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells, J. Biol. Chem. 270, 815-822 (1995).
97. 97. B. CHEATHAM, C. J. VLAHOS, L. CHEATHAM, L. WANG, J. BLENIS, C. R. KAHN, Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation, Mol. Cell. Biol. 14, 4902-4911 (1994).
98. 98. K. O. HARTLEY, D. GELL, G. C.M. SMITH, H. ZHANG, N. DIVECHA, M. A. CONNELLY, A. ADMON, S. P. LEES-MILLER, C. W. ANDERSON and S. P. JACKSON, DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product, Cell 82, 849-856 (1995).
99. 99. C. J. VLAHOS, W. F. MATTER, K. Y. HUI and R. F. BROWN, A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002), J. Biol. Chem. 269, 5241-5248 (1994).
100. 100. R. MENDEZ, M. G. MYERS Jr., M. F. WHITE and R. E. RHOADS, Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase, Mol. Cell. Biol. 16, 2857-2864 (1996).
101. 101. J. DOWNWARD, Regulating S6 kinase, Nature 371, 378-379 (1994).
102. s6k is associated with phosphorylation of four clustered sites displaying Ser/Thr-Pro motifs, Proc. Natl Acad. Sci. U.S.A. 89, 7282-7286 (1992).
103. 103. U. K. LAEMMLI, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680-685 (1970).